Streetbeat News

Analyst Ratings

CVNA

Wedbush analyst Seth Basham maintains a Neutral rating on Carvana (NYSE:CVNA) but raises the price target from $150 to $175.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:48 pm

CLOV

Clover Health Investments shares are trading lower following UBS's initiation of coverage with a Neutral rating and a price target of $4.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:48 pm

HALO

Halozyme Therapeutics shares declined following a downgrade by Wells Fargo from Overweight to Equal-Weight.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:46 pm

APD

Vertical Research has upgraded Air Products & Chemicals (NYSE:APD) from Hold to Buy, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:46 pm

CVS

CVS Health has seen unusual options activity with over 14 trades totaling $1,086,658. The stock is currently priced at $64.72, with a slight increase of 0.2%. Analysts have mixed ratings, with price targets ranging from $62 to $85. The options activity suggests a focus on a price band between $30 and $67.5.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 4:45 pm

BLK

Morgan Stanley analyst Mike Cyprys maintains an Overweight rating on BlackRock and raises the price target from $1036 to $1150.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:45 pm

CVX

The options market shows a bearish sentiment towards Chevron (CVX), with 45% of trades being bearish. Significant investors predict a price range of $95 to $160. Analysts maintain positive ratings with target prices up to $189. CVX is currently priced at $151.69, with RSI indicating it may be overbought.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 4:45 pm

AMZN

Amazon's stock is experiencing a decline following a downgrade by Wells Fargo from Overweight to Equal-Weight, with a price target reduction from $225 to $183.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:45 pm

SCHW

Morgan Stanley analyst Michael Cyprys has maintained an Equal-Weight rating on Charles Schwab (NYSE:SCHW) but has lowered the price target from $70 to $68.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:43 pm

PTLO

Stephens & Co. analyst Jim Salera has downgraded Portillos (NASDAQ:PTLO) from Overweight to Equal-Weight, indicating a more neutral stance on the stock.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:43 pm